ArticleBMC medical genomics2025
A novel frameshift variation of PKD1 in familial autosomal dominant polycystic kidney diseases: expanding the clinical phenotype and genetic spectrum of PKD1 disorders.
Article in BMC medical genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundAutosomal dominant polycystic kidney disease is a common monogenic hereditary kidney disorder. Mutations in the PKD1 gene lead to the development of fluid-filled cysts in the kidney, liver, and other organs, which can eventually result in end-stage renal failure. Affected individuals have a 50% chance of passing the mutation to each of their offspring. Families with ADPKD are advised to undergo genetic testing to causative variants and would benefit from genetic counseling to reduce the inherited risk.
methodWe performed genetic analysis on a family with ADPKD. DNA samples extracted from the peripheral blood of ADPKD patients were subjected to whole exome sequencing (WES) analysis. Variations were assessed in accordance with the American College of Medical Genetics and Genomic (ACMG) guidelines. Moreover, recent literature focusing on newly identified pathogenic PKD1 mutations and their clinical manifestations was summarized in this study.
resultA novel heterozygous variant in the PKD1 gene [NM_001009944.2, c. 5733_5751dup GGCTGCCGGCTCAGCTGTC (p.Thr1918Glyfs*78)] was identified. The variant was absent in published database and resulted in a frameshift mutation predicted to lead to premature termination of the protein translation. The comprehensive analysis of population frequency, conservation, structural and pathogenicity prediction suggested that this variant was classified as pathogenic.
conclusionThis is the first reported ADPKD case caused by this novel PKD1 variant. This finding expands the known mutation spectrum of the PKD1 genes and provides a foundation for genetic counseling and future preimplantation genetic diagnosis in affected families. Our findings offer valuable genetic and clinical insights for accurate diagnosis and evaluation of disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.